由SRT1720进行SIRT1依赖的PGC-1α脱乙烯化,通过增强线粒体功能来挽救动脉样硬化的进展

Jin Young Sung1, Seul Gi Kim1, Young Jin Kang2

  • 1Department of Pharmacology, College of Medicine, Yeungnam University, Daegu 42415, Republic of Korea; Senotherapy-based Metabolic Disease Control Research Center, College of Medicine, Yeungnam University, Daegu 42415, Republic of Korea.

概括

SRT1720治疗改善了血管光滑肌细胞 (VSMC) 中的线粒体功能,这些细胞经历了衰老和动脉样硬化. 这种药物减少了氧化应激并修复了线粒体损伤,为动脉样硬化提供了潜在的治疗策略.